Viii. Final Perspectives Viii.6 Advice to a Young Mathematician
نویسنده
چکیده
Borwein, J., D. H. Bailey, and R. Girgensohn. 2004. Experimentation in Mathematics: Computational Paths to Discovery. Wellesley, MA: A. K. Peters. Calkin, N., and H. S. Wilf. 2000. Recounting the rationals. American Mathematical Monthly 107:360–63. Ferguson, H. R. P., and R. W. Forcade. 1979. Generalization of the Euclidean algorithm for real numbers to all dimensions higher than two. Bulletin of the American Mathematical Society 1:912–14. Gessel, I. 1990. Symmetric functions and P -recursiveness. Journal of Combinatorial Theory A53:257–85. Graham, R. L., D. E. Knuth, and O. Patashnik. 1989. Concrete Mathematics. Reading, MA: Addison-Wesley. Greene, C., and Wilf, H. S. 2007. Closed form summation of C-finite sequences. Transactions of the American Mathematical Society 359:1161–89. Lenstra, A. K., H. W. Lenstra Jr., and L. Lovász. 1982. Factoring polynomials with rational coefficients.Mathematische Annalen 261(4):515–34. McKay, B. D., F. E. Oggier, G. F. Royle, N. J. A. Sloane, I. M. Wanless, and H. S. Wilf. 2004. Acyclic digraphs and eigenvalues of (0,1)-matrices. Journal of Integer Sequences 7: 04.3.3. Mills, W. H., D. P. Robbins, and H. Rumsey Jr. 1987. Enumeration of a symmetry class of plane partitions.Discrete Mathematics 67:43–55. Petkovšek, M., and H. S. Wilf. 1996. A high-tech proof of the Mills–Robbins–Rumsey determinant formula. Electronic Journal of Combinatorics 3:R19. Petkovšek, M., H. S. Wilf, and D. Zeilberger. 1996. A = B. Wellesley, MA: A. K. Peters. Wilf, H. S. 1992. Ascending subsequences and the shapes of Young tableaux. Journal of Combinatorial Theory A60: 155–57. . 1994. generatingfunctionology, 2nd edn. New York: Academic Press. (This can also be downloaded at no charge from the author’s Web site.)
منابع مشابه
Detection of Factor VIII Inhibitors in Hemophilia A Patients
Background: Factor VIII administration to hemophilia A patients results in an immune response (inhibitor formation) which significantly complicates the therapy. The present study was performed to determine the prevalence of inhibitor development in hemophilia A patients receiving recombinant factor VIII therapy. Materials and Methods: This was an observational descriptive study. Clotting fac...
متن کاملFACTOR V AND VIII INHIBITOR IN PATIENTS WITH COMBINED FACTOR V AND VIII DEFICIENCY
Patients with coagulation factor(s) deficiency who use coagulation therapy are susceptible to forming inhibitors against coagulation factor(s). In this survey we detected factor V and VIII inhibitor in ten patients with combined deficiency of factors V and VIII from north east of Iran (Khorassan province). It was revealed in our survey that eight patients had both factor V and factor VIII i...
متن کاملفراوانی هپاتیتB ، هپاتیتC و ارتباط آنها با ایجاد مهار کننده فاکتور VIII در مبتلایان هموفیلی استان همدان- 1383
Abstract: Background: Hemophilia is a x-linked deficiency of factor VIII. The aim of the present study was to determine the frequencies of hepatitis B and C infections, markers of inflammation and liver function tests and also to assess the possible association between factor VIII inhibitor and hepatitis B and C infections in hemophiliacs of Hamedan Province of Iran. Materials and methods: Si...
متن کاملTHE ROLE OF VARIOUS STABILIZERS IN THE ACQUISITION OF THERMO-TOLER ANCE IN FACTOR VIII ACTIVITY
We prepared a highly purified and relatively heat stable form of factor VIII which contained 25 units per mL (u/mL) activity using PEG-4000 and developed an effective and new manufacturing process. Heat treatment was performed at 80°C for 72 hrs in the presence of different stabilizers. In our studies, we used different organic solvents as preservatives to maintain factor VIII activity, sin...
متن کاملبررسی زمان تاخیری از جداسازی پلاسما تا انجماد بر فعالیت فاکتور VIII در پلاسمای تازه منجمد
چکید ه سابقه و هدف پلاسما فرآوردهای مهم در جهت تولید فاکتورهای انعقادی کنسانتره به شمار میآید. فاکتور VIII یکی از مهمترین فاکتورهای ناپایدار موجود در پلاسما میباشد که فعالیت آن به عنوان شاخص کیفی این فرآورده مطرح میشود. از این رو مطلوبسازی کلیه مراحل تهیه پلاسما به منظور اجتناب از کاهش فاکتور VIII ، امری ضروری به نظر میرسد. در این مطالعه، تاثیر زمان تاخیری از جداسازی پلاسما تا انجم...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2008